Keywords

Angiotensin II, Shock, Tricyclic overdose

 

Authors

  1. Ferdowsali, Jacqueline DNP, MSN, BSN, ACNPC-AG
  2. Ferdowsali, Kameron MD

Abstract

This case report explores the novel use of angiotensin II (Giapreza) for the treatment of vasodilation in the setting of a tricyclic overdose. The purpose of this case is to describe how the use of angiotensin II can improve hemodynamic parameters and result in a dose reduction of other catecholamine vasopressors in vasodilatory shock. The use of angiotensin II is new to clinical practice and has the potential to change outcomes for patients.